Lewis Joel has bought 9,175 shares of Galectin Therapeutics Inc [GALT] at $2.10 a share.
Galectin Therapeutics Inc [GALT] disclosed in an SEC Form 4 submission Friday, March 31, 2023 that the deal increased Lewis Joel's holding in the company to 839,614.
Galectin Therapeutics Inc [GALT] is a Pharmaceutical Preparations company based in Nevada.
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.